Tesamorelin

Supplier: Elite Bioscience® Product: Tesamorelin 5mg x 1 vial Active Ingredient: Tesamorelin, TH9507, Egrifta (C221H366N72O67) Half-Life: Tesamorelin has an approximate 1.2 hours, is typically administered subcutaneous injection daily. Dosage and packing: 5 mg multi-dose Tesamorelin glass vial   Package Description: Tesamorelin (also known as Egrifta) is an FDA-approved injectable growth hormone-releasing hormone (GHRH) analogue used to reduce excess abdominal fat in HIV-associated lipodystrophy. It stimulates the pituitary gland to release growth hormone (GH), which helps regulate metabolism, reduce visceral fat, and improve body composition. Tesamorelin should be used alongside a healthy diet and regular exercise for optimal results. What Is Tesamorelin®? Tesamorelin is not a stimulant, meaning you won’t experience side effects like insomnia, jitteriness, or restlessness. It is a synthetic peptide that mimics the body’s natural GHRH to enhance growth hormone production, which in tur